140 related articles for article (PubMed ID: 35496040)
21. Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas.
Chen JQ; Zhan WH; He YL; Peng JS; Wang JP; Cai SR; Ma JP
World J Gastroenterol; 2004 Mar; 10(6):776-82. PubMed ID: 15040016
[TBL] [Abstract][Full Text] [Related]
22. Correlation of lymph node metastases and expression of matrix metalloproteinase-7 in patients with gastric cancer.
Ajisaka H; Yonemura Y; Miwa K
Hepatogastroenterology; 2004; 51(57):900-5. PubMed ID: 15143943
[TBL] [Abstract][Full Text] [Related]
23. Correlation of COX-2 and MMP-13 expressions with gastric cancer and their effects on prognosis.
Ren J; Liu J; Sui X
J BUON; 2019; 24(1):187-193. PubMed ID: 30941969
[TBL] [Abstract][Full Text] [Related]
24. Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers.
Emara M; Cheung PY; Grabowski K; Sawicki G; Wozniak M
Clin Chem Lab Med; 2009; 47(8):993-1000. PubMed ID: 19569980
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of MMP21 and MMP28 is associated with gastric cancer progression and poor prognosis.
Zhang J; Pan Q; Yan W; Wang Y; He X; Zhao Z
Oncol Lett; 2018 May; 15(5):7776-7782. PubMed ID: 29731903
[TBL] [Abstract][Full Text] [Related]
26. Coexpression of Matrix Metalloproteinase-7 and Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Biomarker in Gastric Cancer.
Zhang Y; Qin L; Ma X; Wang Y; Wu Y; Jiang J
Dis Markers; 2020; 2020():8831466. PubMed ID: 33005257
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinase-14 is a negative prognostic marker for patients with gastric cancer.
He L; Chu D; Li X; Zheng J; Liu S; Li J; Zhao Q; Ji G
Dig Dis Sci; 2013 May; 58(5):1264-70. PubMed ID: 23314917
[TBL] [Abstract][Full Text] [Related]
28. High serum MMP-14 predicts worse survival in gastric cancer.
Kasurinen A; Tervahartiala T; Laitinen A; Kokkola A; Sorsa T; Böckelman C; Haglund C
PLoS One; 2018; 13(12):e0208800. PubMed ID: 30532247
[TBL] [Abstract][Full Text] [Related]
29. Expression of matrix metalloproteinase-7 involving in growth, invasion, metastasis and angiogenesis of gastric cancer.
Huachuan Z; Xiaohan L; Jinmin S; Qian C; Yan X; Yinchang Z
Chin Med Sci J; 2003 Jun; 18(2):80-6. PubMed ID: 12903787
[TBL] [Abstract][Full Text] [Related]
30. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological significance of matrix metalloproteinase-7 protein expression in esophageal cancer: a meta-analysis.
Miao S; Zhou SY; Han CS; Zhang LN; Sun HB; Yang B
Drug Des Devel Ther; 2015; 9():3729-40. PubMed ID: 26229436
[TBL] [Abstract][Full Text] [Related]
32. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
33. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.
Alakus H; Afriani N; Warnecke-Eberz U; Bollschweiler E; Fetzner U; Drebber U; Metzger R; Hölscher AH; Mönig SP
World J Surg; 2010 Dec; 34(12):2853-9. PubMed ID: 20730428
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis.
Soleyman-Jahi S; Nedjat S; Abdirad A; Hoorshad N; Heidari R; Zendehdel K
PLoS One; 2014; 10(4):e0122316. PubMed ID: 25919283
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of associations between four polymorphisms in the matrix metalloproteinases gene and gastric cancer risk.
Yang TF; Guo L; Wang Q
Asian Pac J Cancer Prev; 2014; 15(3):1263-7. PubMed ID: 24606450
[TBL] [Abstract][Full Text] [Related]
36. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
[TBL] [Abstract][Full Text] [Related]
37. Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley.
Malik MA; Sharma KL; Zargar SA; Mittal B
Saudi J Gastroenterol; 2011; 17(5):301-6. PubMed ID: 21912055
[TBL] [Abstract][Full Text] [Related]
38. [Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2) and MMP-9 genes with risk of gastric cancer in a Chinese population].
Zhang XM; Miao XP; Xiong P; Yu CY; Tan W; Qu SN; Sun T; Zhou YF; Lin DX
Ai Zheng; 2004 Nov; 23(11):1233-7. PubMed ID: 15522165
[TBL] [Abstract][Full Text] [Related]
39. Association of matrix metalloproteinase-7 (-181A/G) promoter polymorphism in chronic pancreatitis.
Manjari KS; Jyothy A; Kumar PS; Prabhakar B; Nallari P; Venkateshwari A
Indian J Med Res; 2014 Nov; 140(5):609-15. PubMed ID: 25579141
[TBL] [Abstract][Full Text] [Related]
40. Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer.
Sharma KL; Misra S; Kumar A; Mittal B
Liver Int; 2012 Sep; 32(8):1278-86. PubMed ID: 22621753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
